Dentsply Sirona Inc (XRAY) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Dentsply Sirona Inc stock (XRAY) is currently trading at $11.46. Dentsply Sirona Inc PS ratio (Price-to-Sales) is 0.59. Analyst consensus price target for XRAY is $14.54. WallStSmart rates XRAY as Hold.
- XRAY PE ratio analysis and historical PE chart
- XRAY PS ratio (Price-to-Sales) history and trend
- XRAY intrinsic value — DCF, Graham Number, EPV models
- XRAY stock price prediction 2025 2026 2027 2028 2029 2030
- XRAY fair value vs current price
- XRAY insider transactions and insider buying
- Is XRAY undervalued or overvalued?
- Dentsply Sirona Inc financial analysis — revenue, earnings, cash flow
- XRAY Piotroski F-Score and Altman Z-Score
- XRAY analyst price target and Smart Rating
Dentsply Sirona Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Dentsply Sirona Inc (XRAY) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around return on equity and operating margin. Fundamentals are solid but monitor weak areas for improvement.
Dentsply Sirona Inc (XRAY) Key Strengths (5)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
109.55% of shares held by major funds and institutions
Trading at 1.63x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Dentsply Sirona Inc (XRAY) Areas to Watch (5)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Modest revenue growth at 6.20%
Solid earnings growth at 15.20%
Dentsply Sirona Inc (XRAY) Detailed Analysis Report
Overall Assessment
This company scores 56/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.77), Price/Sales (0.59), Price/Book (1.63) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Growth concerns include Revenue Growth at 6.20%, EPS Growth at 15.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -36.40%, Operating Margin at 1.77%, Profit Margin at -16.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -36.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 6.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
XRAY Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
XRAY's Price-to-Sales ratio of 0.59x trades at a deep discount to its historical average of 3.35x (0th percentile). The current valuation is 92% below its historical high of 7.05x set in Jun 2006, and 1% above its historical low of 0.59x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.8x as trailing revenue scaled faster than the stock price.
Compare XRAY with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Dentsply Sirona Inc (XRAY) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Dentsply Sirona Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 3.7B with 6% growth year-over-year. The company is currently unprofitable, posting a -16.3% profit margin.
Key Findings
Generating 60M in free cash flow and 101M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -16.3% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Dividend sustainability with a current yield of 5.7%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Dentsply Sirona Inc.
Bottom Line
Dentsply Sirona Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Dentsply Sirona Inc(XRAY)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.